Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2004-8-3
pubmed:abstractText
The use of intravenous contrast agents in magnetic resonance imaging (MRI) has become well established clinical practice. Contrast agents provide additional information in many applications. Gadolinium chelates constitute the largest group of MR contrast agents and are considered to be safe. Different groups of contrast agents are established for clinical application: low concentrated gadolinium chelates, high concentrated gadolinium chelates, superparamagnetic iron oxide particles and hepatobiliary contrast agents. The review discusses the clinical applications and the safety issues involved with administration of intravenous contrast agents in MR imaging. Several approaches of intravascular or blood pool agents are also presented.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
0033-832X
pubmed:author
pubmed:issnType
Print
pubmed:volume
44
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
273-83
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
[Contrast agents in MRT. Substance, effects, pharmacology and validity].
pubmed:affiliation
Zentralinstitut für Bildgebende Diagnostik, Klinikum Karlsruhe. Peter.Reimer@klinik.uni-karlsruhe.de
pubmed:publicationType
Journal Article, English Abstract, Review